IE49577B1 - 8-substituted-4-amino-3-quinolinecarboxylic acids and esters-antisecretory,anti-ulcer compounds - Google Patents
8-substituted-4-amino-3-quinolinecarboxylic acids and esters-antisecretory,anti-ulcer compoundsInfo
- Publication number
- IE49577B1 IE49577B1 IE605/80A IE60580A IE49577B1 IE 49577 B1 IE49577 B1 IE 49577B1 IE 605/80 A IE605/80 A IE 605/80A IE 60580 A IE60580 A IE 60580A IE 49577 B1 IE49577 B1 IE 49577B1
- Authority
- IE
- Ireland
- Prior art keywords
- ethyl
- amino
- quinolinecarboxylate
- methoxy
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2398179A | 1979-03-26 | 1979-03-26 | |
| US06/127,153 US4343804A (en) | 1979-03-26 | 1980-03-04 | 4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE800605L IE800605L (en) | 1980-09-26 |
| IE49577B1 true IE49577B1 (en) | 1985-10-30 |
Family
ID=26697875
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE605/80A IE49577B1 (en) | 1979-03-26 | 1980-03-24 | 8-substituted-4-amino-3-quinolinecarboxylic acids and esters-antisecretory,anti-ulcer compounds |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US4343804A (en:Method) |
| JP (1) | JPH02117663A (en:Method) |
| AR (1) | AR230268A1 (en:Method) |
| AT (1) | AT372373B (en:Method) |
| AU (1) | AU528388B2 (en:Method) |
| BR (1) | BR8001779A (en:Method) |
| CA (1) | CA1147338A (en:Method) |
| CH (1) | CH644105A5 (en:Method) |
| DE (1) | DE3011490A1 (en:Method) |
| DK (1) | DK156056C (en:Method) |
| EG (1) | EG15009A (en:Method) |
| ES (1) | ES8103048A1 (en:Method) |
| FI (1) | FI77452C (en:Method) |
| FR (1) | FR2452485B1 (en:Method) |
| GB (1) | GB2047244B (en:Method) |
| GR (1) | GR68006B (en:Method) |
| HK (1) | HK67983A (en:Method) |
| IE (1) | IE49577B1 (en:Method) |
| IL (1) | IL59628A (en:Method) |
| IN (1) | IN151446B (en:Method) |
| IT (1) | IT1133079B (en:Method) |
| MX (1) | MX6264E (en:Method) |
| NL (1) | NL8001752A (en:Method) |
| NO (1) | NO153927C (en:Method) |
| NZ (1) | NZ193252A (en:Method) |
| PH (1) | PH16416A (en:Method) |
| PL (1) | PL125030B1 (en:Method) |
| PT (1) | PT71008B (en:Method) |
| SE (1) | SE435837B (en:Method) |
| SG (1) | SG33683G (en:Method) |
| YU (1) | YU41702B (en:Method) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8610981D0 (en) * | 1986-05-06 | 1986-06-11 | Ici America Inc | Quinoline amides |
| GB8621425D0 (en) * | 1986-09-05 | 1986-10-15 | Smith Kline French Lab | Compounds |
| GB8804445D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
| GB8804447D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
| GB8804444D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
| GB8804446D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
| GB8804443D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
| GB8804448D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
| US5432182A (en) * | 1989-02-23 | 1995-07-11 | Smithkline Beecham Intercredit B.V. | Compounds substituted quinoline derivatives |
| CA2011086A1 (en) * | 1989-03-17 | 1990-09-17 | Karl-Heinz Geiss | 2-alkyl-4-arylmethylaminoquinolines, the use thereof and drugs prepared therefrom |
| DE3917233A1 (de) * | 1989-05-26 | 1990-11-29 | Basf Ag | 8-substituierte 4-(heterocyclylmethylamino)-chinoline, ihre verwendung und daraus hergestellte arzneimittel |
| GB8918265D0 (en) * | 1989-08-10 | 1989-09-20 | Smithkline Beckman Intercredit | Compounds |
| US5362743A (en) * | 1993-03-09 | 1994-11-08 | Pfizer Inc. | Aminoquinoline derivatives |
| IS4164A (is) * | 1993-06-11 | 1994-12-12 | Ab Astra | Efnasambönd sem hindra flæði magasýru |
| US5556863A (en) * | 1993-06-11 | 1996-09-17 | Astra Aktiebolag | Compound for gastric acid secretion inhibition |
| PT720601E (pt) * | 1993-08-10 | 2001-02-28 | Black James Foundation | Ligandos de receptores de gastrina e cck |
| US5650415A (en) * | 1995-06-07 | 1997-07-22 | Sugen, Inc. | Quinoline compounds |
| KR0169813B1 (ko) * | 1995-07-12 | 1999-01-15 | 김종인 | 4-아미노-3-아실나프티리딘 유도체 |
| US5760041A (en) * | 1996-02-05 | 1998-06-02 | American Cyanamid Company | 4-aminoquinazoline EGFR Inhibitors |
| US6875769B2 (en) * | 1996-05-23 | 2005-04-05 | Pfizer Inc. | Substituted6,6-hetero-bicyclicderivatives |
| US5929080A (en) * | 1997-05-06 | 1999-07-27 | American Cyanamid Company | Method of treating polycystic kidney disease |
| US6251912B1 (en) | 1997-08-01 | 2001-06-26 | American Cyanamid Company | Substituted quinazoline derivatives |
| US6323209B1 (en) | 1997-11-06 | 2001-11-27 | American Cyanamid Company | Method of treating or inhibiting colonic polyps |
| NZ510580A (en) | 1998-09-29 | 2003-03-28 | American Cyanamid Co | Substituted 3-cyanoquinolines useful as protein tyrosine kinases inhibitors |
| CA2395772C (en) * | 1999-12-28 | 2010-09-28 | Eisai Co., Ltd. | Sulfonamide-containing heterocyclic compounds |
| US6521618B2 (en) | 2000-03-28 | 2003-02-18 | Wyeth | 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
| US6576644B2 (en) * | 2000-09-06 | 2003-06-10 | Bristol-Myers Squibb Co. | Quinoline inhibitors of cGMP phosphodiesterase |
| UA80393C2 (uk) | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
| MY140561A (en) | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
| KR20110010824A (ko) | 2003-01-14 | 2011-02-07 | 아레나 파마슈티칼스, 인크. | 대사 조절제로서의 1,2,3-삼치환된 아릴 및 헤테로아릴 유도체, 및 당뇨병 및 고혈당증을 비롯한 이에 관련된 장애의 예방 및 치료 |
| JP4742026B2 (ja) | 2003-03-10 | 2011-08-10 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | ロフルミラストの新規の製造方法 |
| EP2287166A3 (en) * | 2003-07-14 | 2011-06-22 | Arena Pharmaceuticals, Inc. | Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| US8663694B2 (en) * | 2005-03-16 | 2014-03-04 | Takeda Gmbh | Taste masked dosage form containing roflumilast |
| WO2011022216A1 (en) * | 2009-08-17 | 2011-02-24 | High Point Pharmaceuticals, Llc | Substituted pyridine derivatives, pharmaceutical compositions, and methods of use to treat oxidative stress |
| ES2937386T3 (es) | 2010-01-27 | 2023-03-28 | Arena Pharm Inc | Procesos para la preparación de ácido (R)-2-(7-(4-ciclopentil-3-(trifluorometil)benciloxi)-1,2,3,4-tetrahidrociclopenta[b]indol-3-il)acético y sales del mismo |
| EP3323818A1 (en) | 2010-09-22 | 2018-05-23 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| ES2995737T3 (en) | 2015-01-06 | 2025-02-11 | Arena Pharm Inc | Compound for use in treating conditions related to the s1p1 receptor |
| US10301262B2 (en) | 2015-06-22 | 2019-05-28 | Arena Pharmaceuticals, Inc. | Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compund1) for use in SIPI receptor-associated disorders |
| PL3538512T3 (pl) * | 2016-11-11 | 2021-11-22 | Bayer Animal Health Gmbh | Nowe pochodne chinolino-3-karboksyamidu o działaniu przeciw robakom pasożytniczym |
| WO2018151873A1 (en) | 2017-02-16 | 2018-08-23 | Arena Pharmaceuticals, Inc. | Compounds and methods for treatment of primary biliary cholangitis |
| EP3700527A4 (en) * | 2017-10-25 | 2021-03-10 | Children's Medical Center Corporation | PAPD5 INHIBITORS AND METHOD OF USING THEM |
| MX2020011873A (es) | 2018-05-09 | 2021-01-20 | Bayer Animal Health Gmbh | Nuevos derivados de quinolina. |
| KR102859841B1 (ko) | 2018-06-06 | 2025-09-12 | 아레나 파마슈티칼스, 인크. | S1p1 수용체와 관련된 병태의 치료 방법 |
| CN113993848A (zh) | 2019-04-24 | 2022-01-28 | 儿童医学中心公司 | Papd5抑制剂及其使用方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3470186A (en) * | 1967-06-02 | 1969-09-30 | American Cyanamid Co | Substituted 4-anilino-3-quinolinecarboxylic acids and esters |
| JPS4838712A (en:Method) * | 1971-09-18 | 1973-06-07 |
-
1980
- 1980-03-04 US US06/127,153 patent/US4343804A/en not_active Expired - Lifetime
- 1980-03-14 IL IL59628A patent/IL59628A/xx unknown
- 1980-03-22 GR GR61513A patent/GR68006B/el unknown
- 1980-03-24 MX MX808722U patent/MX6264E/es unknown
- 1980-03-24 AT AT0156480A patent/AT372373B/de not_active IP Right Cessation
- 1980-03-24 FI FI800910A patent/FI77452C/fi not_active IP Right Cessation
- 1980-03-24 IE IE605/80A patent/IE49577B1/en unknown
- 1980-03-24 FR FR8006516A patent/FR2452485B1/fr not_active Expired
- 1980-03-25 SE SE8002292A patent/SE435837B/sv not_active IP Right Cessation
- 1980-03-25 NO NO800858A patent/NO153927C/no unknown
- 1980-03-25 EG EG80174A patent/EG15009A/xx active
- 1980-03-25 IN IN345/CAL/80A patent/IN151446B/en unknown
- 1980-03-25 DK DK128380A patent/DK156056C/da not_active IP Right Cessation
- 1980-03-25 CH CH234080A patent/CH644105A5/fr not_active IP Right Cessation
- 1980-03-25 DE DE19803011490 patent/DE3011490A1/de active Granted
- 1980-03-25 BR BR8001779A patent/BR8001779A/pt unknown
- 1980-03-25 PT PT71008A patent/PT71008B/pt unknown
- 1980-03-25 GB GB8009991A patent/GB2047244B/en not_active Expired
- 1980-03-25 NL NL8001752A patent/NL8001752A/nl not_active Application Discontinuation
- 1980-03-25 ES ES489887A patent/ES8103048A1/es not_active Expired
- 1980-03-25 NZ NZ193252A patent/NZ193252A/en unknown
- 1980-03-25 PH PH23804A patent/PH16416A/en unknown
- 1980-03-25 PL PL1980222993A patent/PL125030B1/pl unknown
- 1980-03-26 CA CA000348417A patent/CA1147338A/en not_active Expired
- 1980-03-26 AU AU56848/80A patent/AU528388B2/en not_active Ceased
- 1980-03-26 IT IT67465/80A patent/IT1133079B/it active
- 1980-03-26 AR AR280455A patent/AR230268A1/es active
- 1980-03-26 YU YU844/80A patent/YU41702B/xx unknown
-
1983
- 1983-06-13 SG SG336/83A patent/SG33683G/en unknown
- 1983-12-15 HK HK679/83A patent/HK67983A/xx unknown
-
1989
- 1989-09-26 JP JP1250369A patent/JPH02117663A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE49577B1 (en) | 8-substituted-4-amino-3-quinolinecarboxylic acids and esters-antisecretory,anti-ulcer compounds | |
| SU1227113A3 (ru) | Способ получени 2-/4/дифенилметил/-1-пиперазинил/-ацетамида или его солей присоединени нетоксичных фармацевтически приемлемых кислот | |
| US3669968A (en) | Trialkoxy quinazolines | |
| FI64159C (fi) | Foerfarande foer framstaellning av oralt effektiva antiallergiska 11-oxo-11-h-pyrido(2,1-b)-kinazoliner | |
| AU648394B2 (en) | 4-aryl-thiazole or imidazole derivatives | |
| DE2740588A1 (de) | Imidazo- eckige klammer auf 1,2-a eckige klammer zu -chinolin-2-carbon- saeuren und deren derivate sowie pharmazeutische zubereitungen, die diese verbindungen enthalten | |
| HU217623B (hu) | Eljárás kondenzált tieno- és pirrolo [3,2-c]piridin-2-karbonsav-származékok valamint e vegyületeket tartalmazó gyógyászati készítmények előállítására | |
| FI62313C (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 2,3-dihydroimidazo(2,1-b)tiazolderivat | |
| US6028081A (en) | Substituted quinolone derivatives and pharmaceuticals containing the same | |
| PL161961B1 (en) | Method for manufacturing new derivatives of aminophenyl aminomethylenoamine | |
| US4357333A (en) | N-Substituted 2-(8-halo and trifluoromethyl 4-quinolylamino)benzamides and analgesic use thereof | |
| EP0105131B1 (en) | 2-(omega-alkylaminoalkyl)- and 2-(omega-dialkylaminoalkyl)-3-(4-x-benzylidene)-phthalimidines | |
| US3843656A (en) | 2-methylamino-4'-methyl-4-piperazinyl-6-chloro-5-methylthio-pyrimidine,salts thereof,and process for their preparation | |
| KR840000768B1 (ko) | 4-아미노-3-퀴놀린카복실산 및 에스테르의 제조방법 | |
| CA1161757A (en) | 4-amino-3-quinolinecarboxylic acids and esters- antisecretory, anti-ulcer compounds | |
| CA1051436A (en) | 4-amino-amphetamine derivatives | |
| US4333951A (en) | 2-Amino-6-biphenylacetic acids | |
| IE45144B1 (en) | Aminoalkyl esters of carbamimidothioic acid and compositions having immunosuppressant activity | |
| EP0089426B1 (en) | 2-amino-6-biphenylacetic acids | |
| CS216527B2 (cs) | Způsob výroby 4-amino-3-chinolinkarboxylových kyselin a jejich esterů | |
| Orth et al. | Cyclized Substituted Thioureas I. Preparation of Some 3-Substituted 1, 2, 3, 4-Tetrahydroquinazoline-2-thiones and Their Intermediates | |
| DD298915A5 (de) | Verfahren zur herstellung von pharmakologisch wirksamen 3-aminopyrrolen | |
| SK278791B6 (sk) | Izochinolínové deriváty, spôsob ich výroby a farma | |
| FI57403C (fi) | Foerfarande foer framstaellning av blodtryckssaenkande 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner | |
| PL160232B1 (pl) | Sposób wytwarzania nowych pochodnych chloroani l i ny PL |